Loading company…
Prolific Machines develops a light-based cell manufacturing platform for therapeutics, food proteins and cultured meat.
Based in California, Prolific Machines develops a photomolecular platform that uses light-sensitive proteins to control cellular processes. The technology is intended for therapeutic proteins, food proteins, cultured meat, disease models and regenerative medicine. In May 2024, the company raised USD 55 million in Series B funding led by Ki Tua Fund, as part of a larger USD 86.5 million series B and debt funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in